Back to Search Start Over

Usp22 is an intracellular regulator of systemic emergency hematopoiesis

Authors :
Nikolaus Dietlein
Xi Wang
Jonas Metz
Olivier Disson
Fuwei Shang
Celine Beyersdörffer
Esther Rodríguez Correa
Daniel B. Lipka
Yvonne Begus-Nahrmann
Robyn Laura Kosinsky
Steven A. Johnsen
Marc Lecuit
Thomas Höfer
Hans-Reimer Rodewald
German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ)
Universität Heidelberg [Heidelberg] = Heidelberg University
Nanjing Medical University
Biologie des Infections - Biology of Infection
Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
Otto-von-Guericke-Universität Magdeburg = Otto-von-Guericke University [Magdeburg] (OVGU)
University Medical Center Göttingen (UMG)
Mayo Clinic [Rochester]
Robert Bosch Centre for Tumor Diseases [Stuttgart, Germany] (RBCT)
Centre National de Référence Listeria - National Reference Center Listeria (CNR)
Centre collaborateur de l'OMS Listeria / WHO Collaborating Centre Listeria (CC-OMS / WHO-CC)
Institut Pasteur [Paris] (IP)-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO)-Université Paris Cité (UPCité)
CHU Necker - Enfants Malades [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
N.D. was supported by a Helmholtz Graduate School for Cancer Research fellowship
D.B.L. was supported by Deutsche Krebshilfe Grant 70112574
M.L. and O.D. were supported by Institut Pasteur and Inserm core funding
H.-R.R. and T.H. were supported by Sonderforschungsbereich (SFB) 873-B11
and H.-R.R. was supported by the European Research Council Advanced Grant 742883, the Helmholtz I & I Initiative program, and the Leibniz program of the Deutsche Forschungsgemeinschaft.
Source :
Science Immunology, Science Immunology, 2022, 7 (78), ⟨10.1126/sciimmunol.abq2061⟩
Publication Year :
2022
Publisher :
HAL CCSD, 2022.

Abstract

Emergency hematopoiesis is a concerted response aimed toward enhanced protection from infection, involving multiple cell types and developmental stages across the immune system. Despite its importance, the underlying molecular regulation remains poorly understood. The deubiquitinase USP22 regulates the levels of monoubiquitinated histone H2B (H2Bub1), which is associated with activation of interferon responses upon viral infection. Here, we show that in the absence of infection or inflammation, mice lacking Usp22 in all hematopoietic cells display profound systemic emergency hematopoiesis, evident by increased hematopoietic stem cell proliferation, myeloid bias, and extramedullary hematopoiesis. Functionally, loss of Usp22 results in elevated phagocytosis by neutrophilic granulocytes and enhanced innate protection against Listeria monocytogenes infection. At the molecular level, we found this state of emergency hematopoiesis associated with transcriptional signatures of myeloid priming, enhanced mitochondrial respiration, and innate and adaptive immunity and inflammation. Augmented expression of many inflammatory genes was linked to elevated locus-specific H2Bub1 levels. Collectively, these results demonstrate the existence of a tunable epigenetic state that promotes systemic emergency hematopoiesis in a cell-autonomous manner to enhance innate protection, identifying potential paths toward immune enhancement.

Details

Language :
English
ISSN :
24709468
Database :
OpenAIRE
Journal :
Science Immunology, Science Immunology, 2022, 7 (78), ⟨10.1126/sciimmunol.abq2061⟩
Accession number :
edsair.doi.dedup.....fc672a736876218aece270d8b36a66e9
Full Text :
https://doi.org/10.1126/sciimmunol.abq2061⟩